JAXIALLE
LIVE

Serial Number

79330110

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Nov 17, 2021

Add to watchlist:

No watchlists yet
View on USPTO

JAXIALLE Trademark

Serial Number: 79330110 • Registration: 6777010

JAXIALLE is a trademark filed by NOVARTIS AG on November 17, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,165 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

November 17, 2021

Registration Date

July 5, 2022

Published for Opposition

April 19, 2022

Cancellation Date

June 3, 2025

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Feb 12, 2026 DENA
DEATH OF INTERNATIONAL REGISTRATION
Feb 12, 2026 DETH
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Dec 25, 2025 DENA
DEATH OF INTERNATIONAL REGISTRATION
Dec 25, 2025 DETH
NOTIFICATION PROCESSED BY IB
Sep 25, 2022 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Sep 6, 2022 FICS
FINAL DISPOSITION PROCESSED
Sep 6, 2022 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Aug 4, 2022 GPAR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 5, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 5, 2022 R.PR
NOTIFICATION PROCESSED BY IB
May 9, 2022 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 19, 2022 NPUB
PUBLISHED FOR OPPOSITION
Apr 19, 2022 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 13, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 13, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 30, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 17, 2022 CNSA
ASSIGNED TO EXAMINER
Mar 16, 2022 DOCK
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 26, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 26, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jan 26, 2022 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 26, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 26, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 26, 2022 COAR
APPLICATION FILING RECEIPT MAILED
Jan 14, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 10, 2022 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jan 8, 2022 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Dec 30, 2021 SDRC